Tag: Abivax
Abivax: excellent results in a phase 2b study for ABX464 – 04/06/2022 at 18:12
(AOF) – Good news for Abivax. The company announced on Wednesday evening excellent efficacy and safety results after one year of treatment in the phase 2b maintenance study of ABX464…
Abivax announces excellent clinical results in UC – 04/06/2022 at 18:30
(Photo credits: Adobe Stock – ) (CercleFinance.com) – Abivax today reports ‘excellent clinical results’ from a Phase 2b study of daily treatment with 50 mg of ABX464 in patients with…
Abivax: Announces Excellent Clinical Results in UC
(CercleFinance.com) – Abivax reports today ‘excellentclinical results’ obtained in a phase 2b study of daily treatment with 50 mg of ABX464 in patients with ulcerative colitis (UC). The interim analysis…
Abivax estimates to be financed until the end of the third quarter of 2022
By Olivier Cheilan Published on 03/16/2022 at 6:23 p.m. (Boursier.com) —…
Abivax: the EMA endorses the phase 3 clinical program
(CercleFinance.com) – Abivax shares climbed more than 7% on the Paris Stock Exchange on Thursday after a favorable opinion from the European Medicines Agency (EMA), which supports the advancement of…